US Supplement of the Bird & Bird Global Cookie Review

Written By

gigi cheah module
Gigi Cheah

Senior Consultant
China

I'm a technology, telecoms, media and data privacy lawyer, with extensive experience in the legal, regulatory and commercial issues relating to IT procurement, technology licensing, transfer and distribution, large-scale multi-jurisdictional outsourcing arrangements, joint ventures and strategic alliances, data privacy, social media, IoT, ecommerce businesses, fintech and mobile payments.

alex dixie Module
Alex Dixie

Partner
UK

I am a commercial partner and head up the adtech practice working for brands, agencies and tech providers. With a focus on advertising within the broader media, entertainment and sports and technology and communications sectors, I am based in London.

The United States currently does not have a standalone law governing the use of cookies on the federal level. However, in recent years, several states have adopted their own privacy frameworks, with at least five of these (California, Virginia, Colorado, Connecticut, and Utah) in effect or expected to be in effect by the end of 2023. Policymakers in Iowa, Indiana, Montana, and Tennessee have likewise passed similar legislation that will enter into force in upcoming years.

In this new US supplement of the Bird & Bird Global Cookie Review, we explore some of the key requirements in U.S. state privacy laws with respect to the use of cookies and outline important considerations for organisations as they adjust to these new rules. As new laws follow, both across new states and if a federal law is ever actually realised, we will update this supplement accordingly.

Access the US supplement of the Bird & Bird Global Cookie Review here 


Bird and Bird Global Cookie Review

This supplement also forms part of the Bird & Bird Global Cookie Review, which you can access here

View here

Latest insights

More Insights
Colourful building

Fintech Features - October 2024

Oct 11 2024

Read More
Pills lined up on blue background

Feeling unwell after the CJEU’s Lindenapotheke decision?

Oct 10 2024

Read More
flower

AI - Litigation Risks in the UK & the EU

Oct 10 2024

Read More